# Day 3-4 Compliance Audit: Device Selection

**Date:** 2026-02-13  
**Auditor:** Claude (Automated Testing)

---

## Selected Devices (5 Total)

### Device 1: High-Risk Cardiovascular (Clinical Data Expected)
- **Product Code:** DQY (Catheter, Intravascular, Therapeutic)
- **Test Year:** 2024
- **Expected Features:**
  - Clinical data likely: YES/PROBABLE
  - Biocompatibility standards (ISO 10993)
  - Risk: HIGH
  - Special controls expected

---

### Device 2: Powered/Electrical Device
- **Product Code:** GEI (Electrosurgical Unit)
- **Test Year:** 2024
- **Expected Features:**
  - Electrical safety standards (IEC 60601)
  - Risk: MEDIUM
  - Powered device

---

### Device 3: Software-as-Medical-Device (SaMD)
- **Product Code:** QKQ (System, Image Processing, Radiological)
- **Test Year:** 2024
- **Expected Features:**
  - Software standards (IEC 62304, 62366)
  - Digital pathology/radiology
  - Risk: MEDIUM

---

### Device 4: Sterile Implant
- **Product Code:** KWP (Fixation Appliance, Spinal, Spondylolisthesis)
- **Test Year:** 2024
- **Expected Features:**
  - Sterilization standards (ISO 11135/11137)
  - Biocompatibility standards (ISO 10993)
  - Risk: HIGH
  - Implantable

---

### Device 5: Device with Recall History
- **Product Code:** FRO (Dressing, Wound, Hydrogel)
- **Test Year:** 2024
- **Expected Features:**
  - Potentially recalls in product code
  - Combination product possible
  - Risk: MEDIUM

---

**Selection Rationale:**
- Covers Class II and Class III devices
- Spans medical specialties (cardio, surgery, imaging, ortho, wound care)
- Tests all Phase 2 intelligence categories (clinical, electrical, software, sterile)
- Diverse risk profiles and regulatory requirements

**Next Step:** Run enrichment on each product code
